Migraine affects many individuals worldwide, yet many patients remain undiagnosed or undertreated, highlighting a widespread, unmet need that calls for new drugs and pathways for migraine treatment.

Please provide your email address to receive an email when new articles are posted on . A retrospective claims analysis included more than 184,000 individuals with migraine who used at least one ...

If you're one of the 37 million Americans who get migraine headaches, you know these painful headaches can make you miss work or school and can last several days if they're not treated. In some cases, ...

The risk of autism disorders was slightly, but not significantly, elevated with both triptan late discontinuation trajectories. (HealthDay News) — Children prenatally exposed to different triptan ...

Please provide your email address to receive an email when new articles are posted on . Children born to mothers who used triptans for their migraines during pregnancy did not have a greater risk for ...

June 18, 2007 (Chicago) -- During a migraine attack, physicians stress the importance of taking triptans early to achieve optimal efficacy. Results of a new study, however, indicate that 42% of ...

Insufficient response to triptans is associated with poor health-related quality of life and lower work productivity in migraineurs compared with those who respond well to the medications, according ...

This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...

Telcagepant may help migraineurs who get no relief from current drugs. April 24, 2010— -- Scandinavian researchers writing in The Lancet gave a warm review to an investigational drug for migraine ...